Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

135 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells.
Friesen C, Herr I, Krammer PH, Debatin KM. Friesen C, et al. Among authors: herr i. Nat Med. 1996 May;2(5):574-7. doi: 10.1038/nm0596-574. Nat Med. 1996. PMID: 8616718
Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis.
Ehret A, Westendorp MO, Herr I, Debatin KM, Heeney JL, Frank R, Krammer PH. Ehret A, et al. Among authors: herr i. J Virol. 1996 Sep;70(9):6502-7. doi: 10.1128/JVI.70.9.6502-6507.1996. J Virol. 1996. PMID: 8709290 Free PMC article.
Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children.
Bäumler CB, Böhler T, Herr I, Benner A, Krammer PH, Debatin KM. Bäumler CB, et al. Among authors: herr i. Blood. 1996 Sep 1;88(5):1741-6. Blood. 1996. PMID: 8781430
Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction.
Debatin KM, Beltinger C, Böhler T, Fellenberg J, Friesen C, Fulda S, Herr I, Los M, Scheuerpflug C, Sieverts H, Stahnke K. Debatin KM, et al. Among authors: herr i. Biochem Soc Trans. 1997 May;25(2):405-10. doi: 10.1042/bst0250405. Biochem Soc Trans. 1997. PMID: 9191126 Review. No abstract available.
Activation of the CD95 system increases with disease progression in human immunodeficiency virus type 1-infected children and adolescents.
Böhler T, Bäumler C, Herr I, Groll A, Kurz M, Debatin KM. Böhler T, et al. Among authors: herr i. Pediatr Infect Dis J. 1997 Aug;16(8):754-9. doi: 10.1097/00006454-199708000-00005. Pediatr Infect Dis J. 1997. PMID: 9271036
The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM. Fulda S, et al. Among authors: herr i. Cancer Res. 1997 Sep 1;57(17):3823-9. Cancer Res. 1997. PMID: 9288794
Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis.
Herr I, Wilhelm D, Böhler T, Angel P, Debatin KM. Herr I, et al. EMBO J. 1997 Oct 15;16(20):6200-8. doi: 10.1093/emboj/16.20.6200. EMBO J. 1997. PMID: 9321399 Free PMC article.
Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases).
Los M, Herr I, Friesen C, Fulda S, Schulze-Osthoff K, Debatin KM. Los M, et al. Among authors: herr i. Blood. 1997 Oct 15;90(8):3118-29. Blood. 1997. PMID: 9376593
TRAIL/Apo-2-ligand-induced apoptosis in human T cells.
Jeremias I, Herr I, Boehler T, Debatin KM. Jeremias I, et al. Among authors: herr i. Eur J Immunol. 1998 Jan;28(1):143-52. doi: 10.1002/(SICI)1521-4141(199801)28:01<143::AID-IMMU143>3.0.CO;2-3. Eur J Immunol. 1998. PMID: 9485194
Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells.
Jeremias I, Kupatt C, Baumann B, Herr I, Wirth T, Debatin KM. Jeremias I, et al. Among authors: herr i. Blood. 1998 Jun 15;91(12):4624-31. Blood. 1998. PMID: 9616159
135 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback